Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Localized sample-based quantum diagonalization for strongly correlated chemistry.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Molecular Quantum Computations on a Protein.

Journal of chemical theory and computation·2026
Same author

Delayed Presentation Increases Complications After Catfish Spine Injuries.

Hand (New York, N.Y.)·2026
Same author

Pulmonary Peak Flow Assessment: An Easy Tool for Cardiac Output Estimation in Hemodynamically Stable Neonates.

International journal of pediatrics·2026
Same author

e-Carbonyl: Electrochemical Synthesis of α-Keto Esters via α-Carbonyl Carbocations.

Organic letters·2025
Same author

Alternating Current for Electrooxidative Nitroso Diels-Alder Reaction on 1,2-Dihydropyridines.

The Journal of organic chemistry·2025

Related Experiment Video

Updated: May 29, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Evidence-based platelet transfusion recommendations in neonates.

Antonio Del Vecchio1, Mario Motta

  • 1Neonatal Intensive Care Unit, Ospedale Di Venere, Bari, Italy. delveccant@libero.it

The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
|September 1, 2011
PubMed
Summary

Platelet transfusions are the primary treatment for thrombocytopenic neonates, but guidelines for prophylactic use lack evidence. New, validated transfusion guidelines are needed to improve neonate safety and outcomes.

More Related Videos

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
10:32

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

Related Experiment Videos

Last Updated: May 29, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
10:32

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

Area of Science:

  • Neonatal medicine
  • Hematology
  • Pediatric critical care

Background:

  • Platelet transfusions are the sole specific therapy for most thrombocytopenic neonates in NICUs.
  • The majority of NICU platelet transfusions (up to 98%) are prophylactic, aimed at preventing bleeding rather than treating active bleeding.
  • Current trigger limits for prophylactic platelet transfusions are often arbitrary, lacking robust evidence.

Purpose of the Study:

  • To highlight the necessity for a comprehensive definition of the benefits and risks associated with prophylactic platelet transfusions in neonates.
  • To address the significant global variability in neonatal platelet transfusion practices due to a lack of concrete evidence.
  • To emphasize the need for evidence-based guidelines to inform transfusion decisions in neonatal thrombocytopenia.

Main Methods:

  • Review of current practices and literature regarding neonatal platelet transfusions.
  • Analysis of the existing evidence (or lack thereof) guiding prophylactic transfusion decisions.
  • Discussion of the reliance on expert opinion and reasoning in current transfusion protocols.

Main Results:

  • There is a lack of evidence-based guidelines for neonatal platelet transfusions, leading to wide variations in practice.
  • Current practices are largely based on expert opinion, not definitive data.
  • The benefits and risks of prophylactic platelet transfusions in neonates require further definition.

Conclusions:

  • New, experimentally validated transfusion paradigms are essential to improve the benefits and safety of platelet transfusions in neonates.
  • Current practices, based on reasoning alone, need to be replaced with evidence-based guidelines.
  • Improved guidelines will enhance acceptance and adherence among neonatologists, ultimately benefiting patient care.